Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Stamps Recall Of Teleflex Percutaneous Thrombolytic Device As Class I
Dec 01 2021
•
By
Brian Bossetta
• Source: Alamy
More from Recalls
More from Policy & Regulation